In December 2025, federal courts consolidated NAION lawsuits into an MDL proceeding in the Eastern District of Pennsylvania
The peptide completed six randomized, double-blind, placebo-controlled clinical trials involving over 900 participants, establishing excellent safety and tolerability
GHK-Cu + AHAs/BHAs: Apply at different times to avoid pH conflicts
From low energy and stubborn fat that doesnt seem to budge, to difficulties with blood sugar balance or frustration with diets that dont last, these challenges can impact confidence, health, and overall quality of life
More compounds mean more options, more data, and ultimately better outcomes
In pharmacology, this is a highly positive signal